HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.

AbstractBACKGROUND:
The discovery of calcium receptors and calcimimetics created the possibility of "pharmacologic parathyroidectomy" (phPTX), which decreased secretion of parathormone (PTH). Parathyroid glands of spontaneously hypertensive rats (SHR) and of patients with primary hyperparathyroidism and hypertension secrete parathyroid hypertensive factor (PHF). Parathyroidectomy decreases blood pressure in these rats and in patients. The present study determined whether phPTX induced by calcimimetics decreases mean arterial blood pressure (MAP) in hypertensive rats.
METHODS:
Hypertensive SHR and normotensive Wistar Kyoto (WKY) rats were used. Clearance experiments were performed and the effect of 1 mg/kg body weight (given intravenously) synthesized NPS R-568 (NPS) on MAP in the presence or absence of thyroparathyroidectomy (TPTX) was monitored.
RESULTS:
The success phPTX and TPTX were proven by a significant decrease in plasma Ca(2+) concentration and a decrease in urinary fractional phosphate excretion (FE Pi). The administration of NPS significantly decreased blood pressure in SHR versus SHR/control: Delta(0-50 min of experiment) MAP -16.5 +/- 2.5 mm Hg v -3.2 +/- 1.5 mm Hg (P < .002). The TPTX decreased blood pressure in SHR versus SHR/control and was not different versus SHR/TPTX/NPS (DeltaMAP: -10.2 +/- 1.6 mm Hg v -3.2 +/- 1.5 mm Hg (P < .01) and v -8.3 +/- 2.2 mm Hg (P = not significant). In normotensive WKY rats application of NPS did not reach significance in DeltaMAP: -6.7 +/- 1.8 mm Hg v -2.6 +/- 2.8 mm Hg (P = not significant) in WKY/control. The TPTX lowered blood pressure in WKY versus WKY/control and remained unchanged versus WKY/TPTX/NPS (DeltaMAP: -11.3 +/- 1.7 mm Hg v -2.6 +/- 2.8 mm Hg (P < .04) and v -11.4 +/- 2.6 mm Hg (P = not significant).
CONCLUSIONS:
We conclude that phPTX with NPS R-568 is responsible for a decrease of MAP in SHR.
AuthorsApolonia Rybczyńska, Konrad Boblewski, Artur Lehmann, Czeslawa Orlewska, Henryk Foks, Krystyna Drewnowska, Anzelm Hoppe
JournalAmerican journal of hypertension (Am J Hypertens) Vol. 18 Issue 3 Pg. 364-71 (Mar 2005) ISSN: 0895-7061 [Print] United States
PMID15797655 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aniline Compounds
  • N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine
  • Phenethylamines
  • Phosphates
  • Propylamines
  • Calcium
Topics
  • Aniline Compounds (pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Calcium (agonists, metabolism)
  • Hyperparathyroidism (surgery)
  • Hypertension (drug therapy)
  • Hypotension (chemically induced)
  • Male
  • Parathyroid Glands (physiology)
  • Parathyroidectomy
  • Phenethylamines
  • Phosphates (metabolism)
  • Propylamines
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: